Back Pain News and Research

Latest Back Pain News and Research

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that the company's Luna 360 Interbody Fusion System has received 510(k) clearance from the U.S. Food and Drug Administration for spinal fusion treatment of symptomatic degenerative disc disease (DDD).

2 Dec 2014

Two medical research bodies announce new research centre to tackle musculoskeletal disorders

A major new research centre to tackle the impact of musculoskeletal disorders on people's ability to work has been announced by two leading medical research bodies.

24 Nov 2014

Sanofi, Genzyme announce FDA approval of Lemtrada for treatment of relapsing forms of MS

Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.

17 Nov 2014

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

5 Nov 2014

BioElectronics to present innovative chronic pain therapy at OTC Pharma Asia Conference

BioElectronics Corporation, the maker of advanced consumer and healthcare medical devices announced today that its Executive Vice President, Dr. Deepak Kotak has been invited to present BioElectronics' innovative chronic pain therapy at the OTC Pharma Asia Conference, on Tuesday, March 3, 2015 in Singapore.

5 Nov 2014

Smokers are three times more likely to develop chronic back pain than nonsmokers, study finds

If you want to avoid chronic back pain, put out the cigarette. A new Northwestern Medicine study has found that smokers are three times more likely than nonsmokers to develop chronic back pain, and dropping the habit may cut your chances of developing this often debilitating condition.

4 Nov 2014

Women with bad backs have renewed hope for better sex lives

Newly published findings from the University of Waterloo are giving women with bad backs renewed hope for better sex lives. The findings—part of the first-ever study to document how the spine moves during sex—outline which sex positions are best for women suffering from different types of low-back pain. The new recommendations follow on the heels of comparable guidelines for men released last month.

27 Oct 2014

Qualified massage therapist can play key role in improving cardiovascular health

Many already view massage as an important approach to relieving muscle pain or as a means to relax. However, working with a qualified massage therapist can also play a significant role in improving cardiovascular health as evidenced by a growing body of research, according to the American Massage Therapy Association.

20 Oct 2014

Bone mineral density not linked to musculoskeletal pain

Bone mineral density does not contribute to musculoskeletal pain, researchers report in findings that shed light on the controversy over whether osteoporosis is a painless disease.

13 Oct 2014

Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

Boehringer Ingelheim today announced that Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States.

8 Oct 2014

Poor body mechanics cause chronic lower back pain

If you want to steer clear of lower back pain, remember this: Arch is good, flat is bad.

7 Oct 2014

AAN releases new position statement on opioids for chronic non-cancer pain

According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain.

30 Sep 2014

Weekly musculoskeletal pain on the rise among young adults

Research from Finland shows an increase in the prevalence of frequent musculoskeletal symptoms in young adults, which suggests the need for early intervention.

29 Sep 2014

ED more prevalent than previously thought

Specialists in treatment of erectile dysfunction recognize that ED is more prevalent than previously recognized.

29 Sep 2014

Thirteen research projects to explore nondrug approaches to manage pain, other health conditions

Thirteen research projects totaling approximately $21.7 million over 5 years will explore nondrug approaches to managing pain and related health conditions such as post-traumatic stress disorder (PTSD), drug abuse, and sleep issues. The effort seeks to enhance options for the management of pain and associated problems in U.S. military personnel, veterans, and their families.

26 Sep 2014

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Elusys Therapeutics, Inc., a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed three phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204).

23 Sep 2014

Covered California unveils ad campaign, awards $14.6M for outreach

And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.

17 Sep 2014

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.

15 Sep 2014

Study provides new recommendations for men with lower back pain

A study using motion capture technology provides new information on the spinal strain produced by various sexual positions-suggesting that one position commonly recommended for all men with low back pain is not actually the best choice, reports a study in the journal Spine.

11 Sep 2014

Groundbreaking study reveals best positions to save spine during and after sex

Contrary to popular belief, spooning is not always the best sex position for those with a bad back, according to new research from the University of Waterloo.

11 Sep 2014

Back Pain News and Research

Latest Back Pain News and Research

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Two medical research bodies announce new research centre to tackle musculoskeletal disorders

Sanofi, Genzyme announce FDA approval of Lemtrada for treatment of relapsing forms of MS

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

BioElectronics to present innovative chronic pain therapy at OTC Pharma Asia Conference

Smokers are three times more likely to develop chronic back pain than nonsmokers, study finds

Women with bad backs have renewed hope for better sex lives

Qualified massage therapist can play key role in improving cardiovascular health

Bone mineral density not linked to musculoskeletal pain

Boehringer Ingelheim announces availability of Striverdi Respimat Inhalation Spray 5 mcg in the U.S.

Poor body mechanics cause chronic lower back pain

AAN releases new position statement on opioids for chronic non-cancer pain

Weekly musculoskeletal pain on the rise among young adults

ED more prevalent than previously thought

Thirteen research projects to explore nondrug approaches to manage pain, other health conditions

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Covered California unveils ad campaign, awards $14.6M for outreach

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Study provides new recommendations for men with lower back pain

Groundbreaking study reveals best positions to save spine during and after sex

Industry Focus eBook - Forensics & Toxicology (1st edition) eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Back Pain News and Research

Latest Back Pain News and Research

Industry Focus eBook - Forensics & Toxicology (1st edition) eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in